Originally Published
MX November/December 2006
GOVERNMENTAL & LEGAL AFFAIRS
Methods and Measurements
The following indicators were highlighted in ipIQ's recent analysis of medical device patents by state and core-based statistical area.
Technology Strength: Provides an overall assessment of intellectual property and innovation by considering a portfolio's quality and quantity aspects.
Current Impact Index (CII): Showcases the broader significance of a company's patent portfolio by examining how influential its patents are across the industry and in specific product categories. It measures a portfolio's importance as a foundation for other patents and technologies.
Science Linkage: Reflects the core science referenced in a company's U.S. patents, as measured by the average number of science literature references listed in the patents. A high figure indicates the company is closer to cutting-edge research than its competitors.
Technology Cycle Time: Indicates a firm's speed in turning proprietary research and innovation into intellectual property.
Patent Count: Equals the number of U.S. patents awarded, excluding design and other special-case inventions.
Copyright ©2006 MX
